FEV1 Improvements with Tiotropium & Long-Acting Beta2-Agonists Added to Inhaled Corticosteroid Therapy Are Similar in Pediatric Patients with Asthma.

被引：0
|
作者：
Vogelberg, C. [1 ]
Goldstein, S. [2 ]
Graham, L. [3 ]
Szefler, S. [4 ,5 ]
El Azzi, G. [6 ]
Kallsen, K. [6 ]
Hamelmann, E. [7 ,8 ]
机构：
[1] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Pediat Pulmonol & Allergy, Dresden, Germany
[2] Allergy & Asthma Care Long Isl, Rockville Ctr, NY USA
[3] Childrens Healthcare Atlanta, Pediat Pulmonol, Atlanta, GA USA
[4] Childrens Hosp Colorado, Dept Pediat, Aurora, CO USA
[5] Univ Colorado, Sch Med, Breathing Inst, Aurora, CO USA
[6] Boehringer Ingelheim Pharma GmbH & Co KG, TA Resp Dis, Ingelheim, Germany
[7] Evangel Klinikum Bethel, Klin Kinder & Jugendmed, Bielefeld, Germany
[8] Ruhr Univ, Allergy Ctr, Bochum, Germany
来源：
PEDIATRIC PULMONOLOGY | 2018年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
A67
引用
收藏
页码：S97 / S100
页数：4
相关论文
共 50 条
  • [31] The effect of Combination Therapy of Inhaled Corticosteroids and Long-acting Beta2-agonists on Acute Exacerbation in Moderate to Severe COPD Patients
    Jeong, Hye Cheol
    Ha, Eun Sil
    Jung, Jin Yong
    Lee, Kyung Ju
    Lee, Seung Hyeun
    Kim, Se Joong
    Lee, Eun Joo
    Hur, Gyu Young
    Lee, Sung Yong
    Kim, Je Hyeong
    Lee, Sang Yeub
    Shin, Chol
    Shim, Jae Jeong
    In, Kwang Ho
    Kang, Kyung Ho
    Yoo, Se Hwa
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2005, 59 (02) : 164 - 169
  • [32] Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children
    Ducharme, Francine M.
    Chroinin, Muireann Ni
    Greenstone, Ilana
    Lasserson, Toby J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (05):
  • [33] Why isn't there more controversy on long-acting beta2-agonists in asthma?
    Boussageon, R.
    REVUE DES MALADIES RESPIRATOIRES, 2011, 28 (08) : 1079 - 1080
  • [34] Inhaled corticosteroids versus long-acting beta2-agonists for chronic obstructive pulmonary disease
    Spencer, Sally
    Karner, Charlotta
    Cates, Christopher J.
    Evans, David J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (12):
  • [35] Inhaled corticosteroids versus long-acting beta2-agonists for chronic obstructive pulmonary disease
    Spencer, Sally
    Evans, David J.
    Karner, Charlotta
    Cates, Christopher J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (10):
  • [36] The role of inhaled long-acting beta-2 agonists in the management of asthma
    Kelly, HW
    Harkins, MS
    Boushey, H
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2006, 98 (01) : 8 - 16
  • [37] The Impact Of Tiotropium On Mortality When Added To Inhaled Corticosteroids And Long-Acting Beta Agonist Therapy In COPD
    Short, P. M.
    Anderson, W. J.
    Williamson, P. A.
    Lipworth, S. I. W.
    Elder, D. H. J.
    Schembri, S.
    Lipworth, B. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [38] Erratum to: Cost Effectiveness of Tiotropium in Patients with Asthma Poorly Controlled on Inhaled Glucocorticosteroids and Long-Acting β-Agonists
    Jenny Willson
    Eric D. Bateman
    Ian Pavord
    Adam Lloyd
    Tania Krivasi
    Dirk Esser
    Applied Health Economics and Health Policy, 2016, 14 : 119 - 125
  • [39] Comment on: "Cost Effectiveness of Tiotropium in Patients with Asthma Poorly Controlled on Inhaled Glucocorticosteroids and Long-Acting β-Agonists''
    Samuelsen, Carl
    Bateman, Eric D.
    Pavord, Ian
    Lloyd, Adam
    Baldwin, Mike
    Esser, Dirk
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2016, 14 (01) : 117 - 118
  • [40] Comment on: “Cost Effectiveness of Tiotropium in Patients with Asthma Poorly Controlled on Inhaled Glucocorticosteroids and Long-Acting β-Agonists”
    Carl Samuelsen
    Eric D. Bateman
    Ian Pavord
    Adam Lloyd
    Mike Baldwin
    Dirk Esser
    Applied Health Economics and Health Policy, 2016, 14 : 117 - 118
12345